Option Care Health has seen its share price slide over the past few years, which puts the focus squarely on what investors are really paying for today. The question now is whether the current US$22.90 stock price lines up with the cash flows the business is expected to generate.
- The share price has fallen 31.1% over the last 3 years, which makes the link between today's valuation and the underlying cash generation especially important.
- The company depends heavily on converting its home and alternate site infusion services into consistent free cash flow, which can shape how resilient its valuation is through changes in utilization and reimbursement trends.
- Prefer to judge Option Care Health on earnings? See why Option Care Health's 16.4x P/E tells a different valuation story.
For investors, the debate is whether Option Care Health's current market price is adequately supported by the cash flows implied in a Discounted Cash Flow (DCF) view of the business.
If you want to stress test how this cash flow lens applies beyond Option Care Health, you can compare it with a wider set of 32 high quality undervalued stocks.
Is Option Care Health Getting Expensive on Cash Flow?
The Discounted Cash Flow (DCF) model here focuses on the cash that Option Care Health can return to shareholders over time. Latest twelve month free cash flow is about $301.2 million, so the projections are built on a business that is already generating meaningful cash rather than one that is still heavily cash hungry.
Analysts feeding into this DCF expect free cash flow to soften from current levels before settling into a slower, declining trend over the coming decade. When those forecast cash flows are discounted back, the outcome points to an estimated intrinsic value that is meaningfully below the current US$22.90 share price. For anyone looking at Option Care Health through a cash flow lens, the key question is whether a profile of moderating and then relatively flat free cash generation justifies paying that current market price. Find out what Option Care Health could be worth using our Discounted Cash Flow (DCF) estimate.
The Option Care Health Narrative: What Would Justify Today's Price?
Simply Wall St Narratives for Option Care Health act as the missing link between the DCF result above and the expectations baked into the share price. They spell out which paths for revenue, margins and earnings would need to unfold for the stock to be worth materially more or less than it trades for today on the market. Instead of giving a single figure, these narrative threads map the future that number rests on so you can watch how closely real outcomes track that storyline over time.
One of the top community narratives on Option Care Health: roughly fairly valued
"Recent Street research on Option Care Health points to a more cautious tone, with several bearish analysts reducing ratings and trimming price targets..."
Discover why this Narrative puts Option Care Health at roughly fairly valued.
One more check on Option Care Health that belongs beside the price tag
Before treating Option Care Health as just a valuation story, it is worth knowing that our broader review has flagged specific concerns that sit outside the cash flow math and deserve a closer look. Take a closer look at 1 warning sign before settling on a valuation.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com